Progesterone
- Generic Name
- Progesterone
- Brand Names
- Bijuva, Crinone, Endometrin, Prochieve, Prometrium
- Drug Type
- Small Molecule
- Chemical Formula
- C21H30O2
- CAS Number
- 57-83-0
- Unique Ingredient Identifier
- 4G7DS2Q64Y
- Background
Progesterone is a hormone that occurs naturally in females, and is essential for endometrial receptivity, embryo implantation, and the successful establishment of pregnancy. A low progesterone concentration or an insufficient response to progesterone can cause infertility and pregnancy loss . Progesterone is used in various contraceptive preparations to prev...
- Indication
Gelatinized capsules
The gelatinized capsules are indicated for use in the prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea .
Vaginal gel
...
- Associated Conditions
- Abnormal Uterine Bleeding, Amenorrhea, Endometrial hyperplasia caused by conjugated estrogen, Moderate to Severe Vasomotor Symptoms, Pregnancy, Secondary Amenorrhea, Recurrent spontaneous preterm birth
- Associated Therapies
- Assisted Reproductive Technology therapy
Sex Steroids, Sleep, and Metabolic Dysfunction in Women
- First Posted Date
- 2008-12-09
- Last Posted Date
- 2018-08-01
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 61
- Registration Number
- NCT00805207
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Effects of Hormone Replacement Therapy on the Serotonergic System and Mood in Postmenopausal Women
- Conditions
- Interventions
- First Posted Date
- 2008-09-19
- Last Posted Date
- 2011-07-22
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 30
- Registration Number
- NCT00755963
- Locations
- 🇦🇹
Medical University of Vienna, Dept. of Psychiatry and Psychotherapy, Vienna, Austria
Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia
- Conditions
- Interventions
- First Posted Date
- 2008-07-21
- Last Posted Date
- 2017-04-17
- Lead Sponsor
- John Uckele
- Target Recruit Count
- 3
- Registration Number
- NCT00719537
- Locations
- 🇺🇸
William Beaumont Hospital, Royal Oak, Michigan, United States
A Prospective Randomized Multicentre Study to Compare Crinone 8% Once Daily Versus Other Vaginal Progesterone.
- First Posted Date
- 2008-07-02
- Last Posted Date
- 2008-07-02
- Lead Sponsor
- Nordica Fertility Clinic
- Target Recruit Count
- 2686
- Registration Number
- NCT00708539
- Locations
- 🇸🇪
Reproduktionscentrum, Sahlgrenska, Göteborg, Sweden
🇸🇪Reproduktionscentrum, Stockholm, Sweden
🇸🇪Norrlandsuniversitets sjukhus, Umeå, Sweden
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)
- Conditions
- Interventions
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2022-02-03
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 541
- Registration Number
- NCT00703014
Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)
- Conditions
- Interventions
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2022-02-03
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 344
- Registration Number
- NCT00702273
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715)
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2022-02-03
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 268
- Registration Number
- NCT00702234
Does Hormonal Luteal Support After Intra-uterine Insemination (IUI) Increase the Pregnancy Rate?
- First Posted Date
- 2008-06-18
- Last Posted Date
- 2015-06-25
- Lead Sponsor
- University Hospital, Gasthuisberg
- Target Recruit Count
- 82
- Registration Number
- NCT00700492
- Locations
- 🇧🇪
Leuven University Fertility Center, Leuven, Vlaams Brabant, Belgium
Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)
- Conditions
- Interventions
- First Posted Date
- 2008-06-13
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 682
- Registration Number
- NCT00696878
Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women
- Conditions
- Interventions
- First Posted Date
- 2008-05-12
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 8
- Registration Number
- NCT00676026
- Locations
- 🇺🇸
Yale University School of Medicine; Yale Program for Women's Reproductive Behavioral Health, New Haven, Connecticut, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.